Knowledge Distillery

COVID-19 is an ongoing infectious disease caused by the RNA SARS-CoV-2 virus.

In this study, the authors aimed to determine the rates of cerebral venous sinus thrombosis (CVT) and its impact on outcomes in patients with…

This study investigated the association between COVID-related myalgia experienced by patients at hospital admission and the presence of post-COVID…

The objective of this study was to assess patients Quality of life (QoL) and the burden of their caregivers during COVID-19 pandemic and specifically…

Disease-modifying therapies (DMT) for relapsing-remitting MS (RRMS) act on the immune system, suggesting a need for caution during the…

The main objective of this study was to analyse neurological symptoms during a COVID-19 infection and determine the pattern of symptoms by comparing…

Since vaccination against COVID-19 became available, risks related to vaccinating patients with MS need to be carefully assessed.

The objective of this study was to examine the outcomes of adult patients with spontaneous intracranial and subarachnoid hemorrhage diagnosed with…

Patients with COVID-19 are increasingly reported to suffer from a wide range of neurological complications, affecting both the central and peripheral…

Spinal cord complications associated with COVID-19 are being widely reported.

Coronavirus disease (COVID-19) appeared in December 2019 in the Chinese city of Wuhan and has quickly become a global pandemic.

Considering the similarities with other pandemics due to respiratory virus infections and subsequent development of neurological disorders (e.g.…